Landmark General Hospital, Addis Ababa, Ethiopia.
University Medical Center Groningen, Groningen, The Netherlands.
J Cardiovasc Med (Hagerstown). 2018 Mar;19(3):91-97. doi: 10.2459/JCM.0000000000000617.
Systematic characterization of heart failure in adults in Ethiopia is lacking currently. In this review, we sought to summarize the available scientific evidence on the epidemiology, treatment and prognosis of heart failure in adults in Ethiopia.
A systematic review of PUBMED, EMBASE and SCOPUS was conducted for studies published between January 1990 and July 2017. Studies reporting on incidence, prevalence, treatment or prognosis of heart failure in individuals older than 14 years of age were included.
The search yielded 66 articles, out of which nine were found to be eligible for inclusion in this review. There are no studies reporting the incidence or prevalence of heart failure in the adult population in Ethiopia. There are, however, indications that heart failure might be a significant burden in the country, and typically affects middle-aged adults. Valvular heart disease, predominantly related to rheumatic heart disease, is the most commonly identified heart failure cause across the included studies. There are very limited data on treatment and prognosis.
There is limited scientific evidence on the epidemiology, treatment and prognosis of heart failure in adults in Ethiopia. Further studies are needed for the better understanding of the burden and treatment of heart failure in the adult population in Ethiopia.
目前,埃塞俄比亚缺乏对成人心力衰竭的系统描述。在本综述中,我们旨在总结关于埃塞俄比亚成人心力衰竭的流行病学、治疗和预后的现有科学证据。
对 1990 年 1 月至 2017 年 7 月间发表的 PUBMED、EMBASE 和 SCOPUS 进行了系统检索。纳入了报告 14 岁以上人群心力衰竭发病率、患病率、治疗或预后的研究。
检索到 66 篇文章,其中有 9 篇被认为符合纳入本综述的标准。没有研究报告过埃塞俄比亚成人心力衰竭的发病率或患病率。然而,有迹象表明心力衰竭可能是该国的一个重大负担,并且通常影响中年成年人。在纳入的研究中,瓣膜性心脏病(主要与风湿性心脏病有关)是最常见的心力衰竭病因。关于治疗和预后的数据非常有限。
关于埃塞俄比亚成人心力衰竭的流行病学、治疗和预后的科学证据有限。需要进一步的研究来更好地了解埃塞俄比亚成人心力衰竭的负担和治疗情况。